Carcinogenesis Advance Access originally published online on October 27, 2006
Carcinogenesis 2007 28(4):823-827; doi:10.1093/carcin/bgl196
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press 2006
Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute NIH, DHHS, Bethesda, MD, USA
2 Department of Epidemiology and Public Health, Yale School of Medicine New Haven, USA
3 Pediatric Oncology Branch, Center for Cancer Research NCI, NIH, DHHS, Bethesda, MD, USA
4 International Agency for Research on Cancer Lyon, France
*To whom correspondence should be addressed at: Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, MSC 7240, 6120 Executive Boulevard, EPS 8109, Bethesda, MD 20892-7240, USA. Tel: +1 301 435 4706; Fax: +1 301 402 1819 Email: qingl{at}mail.nih.gov
The caspase proteins are essential for the regulation of normal B cell development and regulation of apoptosis. We investigated five single nucleotide polymorphisms in four key caspase genes, CASP3 [Ex8-280C>A (rs6948) and Ex8+567T>C (rs1049216)], CASP8 Ex14-271A>T (rs13113), CASP9 Ex5+32G>A (rs1052576) and CASP10 Ex3-171A>G (rs3900115) to determine whether they alter risk for non-Hodgkin lymphoma (NHL) in a population-based casecontrol study of women in Connecticut (461 cases and 535 controls). Variants in CASP3 and CASP9 were significantly associated with a decreased risk for NHL, particularly follicular lymphoma [e.g. CASP3 Ex8+567T>C odds ratio (OR)CC+TC = 0.4, 95% confidence interval (CI) = 0.30.7; and CASP9 Ex5+32G>A ORAA+AG = 0.6, 95% CI = 0.41.0]. Further, variants in CASP3, CASP8 and CASP10 were associated with a decreased risk of marginal zone lymphoma and variants in CASP3 and CASP10 were associated with a lower risk of chronic lymphocytic leukemia and related subtypes. The striking protective associations observed for polymorphisms in all four genes for NHL and/or one or more subtypes suggest that genetic variation in CASP genes may play an important role in the etiology of NHL.
Abbreviations: HWE, HardyWeinberg equilibrium; LD, linkage disequilibrium; NHL, non-Hodgkin lymphoma; SNP, single nucleotide polymorphisms
Received May 18, 2006; revised October 5, 2006; accepted October 8, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Rajaraman, S. S. Wang, N. Rothman, M. M. Brown, P. M. Black, H. A. Fine, J. S. Loeffler, R. G. Selker, W. R. Shapiro, S. J. Chanock, et al. Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1655 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Skibola, J. D. Curry, and A. Nieters Genetic susceptibility to lymphoma Haematologica, July 1, 2007; 92(7): 960 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Goldin and S. L. Slager Familial CLL: Genes and Environment Hematology, January 1, 2007; 2007(1): 339 - 345. [Abstract] [Full Text] [PDF] |
||||


